methylphenidate has been researched along with Abnormal Movements in 6 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The importance of DAT in Parkinson's disease (PD) in which DAT may be reduced by 50 to 70% is unclear." | 2.71 | The dopamine transporter: importance in Parkinson's disease. ( Carter, JH; Nutt, JG; Sexton, GJ, 2004) |
| "He developed transient orofacial dyskinesia and upper extremity choreoathetosis as a result which did not abate during his time in the emergency department." | 1.62 | Long-acting Methylphenidate Induced Transient Orofacial Dyskinesia and Upper Extremity Choreoathetosis: A Case Report. ( Anand, V; Trombetta, D; Vik, T, 2021) |
| "Methylphenidate is a stimulant drug commonly prescribed to individuals with attention-deficit/hyperactivity disorder." | 1.48 | Effect of Biperiden Treatment in Acute Orofacial and Extremity Dyskinesia With Methylphenidate Therapy. ( Arslan, E; Arslan, EA; Göksu, Ö; Kilinç, A, 2018) |
| "Methylphenidate-treated children with ADHD had more dyskinesia than children in the control group." | 1.37 | Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder. ( Balázs, J; Czobor, P; Dallos, G; Gádoros, J; Keresztény, A, 2011) |
| "Twenty-seven of the 36 patients had dyskinesias." | 1.35 | PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. ( de la Fuente-Fernandez, R; Mak, E; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ; Troiano, AR, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Trombetta, D | 1 |
| Vik, T | 1 |
| Anand, V | 1 |
| Arslan, EA | 1 |
| Arslan, E | 1 |
| Kilinç, A | 1 |
| Göksu, Ö | 1 |
| Keresztény, Á | 2 |
| Ferenczi-Dallos, G | 1 |
| Velő, S | 1 |
| Gádoros, J | 2 |
| Balázs, J | 2 |
| Troiano, AR | 1 |
| de la Fuente-Fernandez, R | 1 |
| Sossi, V | 1 |
| Schulzer, M | 1 |
| Mak, E | 1 |
| Ruth, TJ | 1 |
| Stoessl, AJ | 1 |
| Dallos, G | 1 |
| Czobor, P | 1 |
| Nutt, JG | 1 |
| Carter, JH | 1 |
| Sexton, GJ | 1 |
1 trial available for methylphenidate and Abnormal Movements
| Article | Year |
|---|---|
The dopamine transporter: importance in Parkinson's disease.
Topics: Aged; Analysis of Variance; Blood Pressure; Dopamine Agents; Dopamine Plasma Membrane Transport Prot | 2004 |
5 other studies available for methylphenidate and Abnormal Movements
| Article | Year |
|---|---|
Long-acting Methylphenidate Induced Transient Orofacial Dyskinesia and Upper Extremity Choreoathetosis: A Case Report.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 2021 |
Effect of Biperiden Treatment in Acute Orofacial and Extremity Dyskinesia With Methylphenidate Therapy.
Topics: Attention Deficit Disorder with Hyperactivity; Biperiden; Central Nervous System Stimulants; Child; | 2018 |
Dyskinesia in Treatment-Naive and Stimulant-Treated Children With ADHD.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 2020 |
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias.
Topics: Caudate Nucleus; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Female; Humans; Logistic | 2009 |
Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula | 2011 |